Tregalizumab Antibody
Tregalizumab (BT-061) is a humanized anti-CD4 monoclonal antibody that selectively activates regulatory T cells (Tregs) by binding a unique epitope. Its application in research includes studying Treg-mediated immunomodulation in autoimmune and inflammatory disease models, both in vitro and in vivo.
Product Specifications
Product Name Alternative
BT 061, BT061, BT-061, Tregalizumab
Target
Immunology/Inflammation related
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
6.21 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
147.41 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
ED0514Hu-01 96 Well
Human Autoantibodies against the C-terminal domain 4, ACAST-D4 ELISA KIT
Sign In for Pricing
View Details ED0514Hu-02 5x 96 Tests
Human Autoantibodies against the C-terminal domain 4, ACAST-D4 ELISA KIT
Sign In for Pricing
View Details ED0514Hu-03 10x 96 Tests
Human Autoantibodies against the C-terminal domain 4, ACAST-D4 ELISA KIT
Sign In for Pricing
View Details